Stock-Based Compensation

6 Months Ended

Jun. 30, 2023

Stock-Based Compensation [Abstract]

Stock-Based Compensation

Note 11 - Stock-Based Compensation

At the 2016 annual meeting of the Company’s stockholders, stockholders approved the Shore Bancshares, Inc. 2016 Stock and Incentive Plan (“2016 Equity Plan”), replacing the Shore Bancshares, Inc. 2006 Stock and Incentive Plan (“2006 Equity Plan”), which expired on that date. The Company may issue shares of common stock or grant other equity-based awards pursuant to the 2016 Equity Plan. Stock-based awards granted to date generally are time-based, vest in equal installments on each anniversary of the grant date and range over a one- to five-year period of time, and, in the case of stock options, expire 10 years from the grant date. Stock-based compensation expense based on the grant date fair value is recognized ratably over the requisite service period for all awards and reflects forfeitures as they occur. The 2016 Equity Plan originally reserved 750,000 shares of common stock for grant, and 472,320 shares remained available for grant at June 30, 2023.

The following tables provide information on stock-based compensation expense for the three and six months ended June 30, 2023 and 2022.

	For Three Months Ended				For the Six Months Ended
	June 30,				June 30,
(Dollars in thousands)	2023		2022		2023		2022
Stock-based compensation expense	$	170	$	172	$	325	$	302
Excess tax benefits (deficiencies) related to stock-based compensation		(1)		2		21		45

	June 30,
(Dollars in thousands)	2023			2022
Unrecognized stock-based compensation expense	$	279		$	461
Weighted average period unrecognized expense is expected to be recognized		0.8	years		0.7	years

The following table summarizes restricted stock award activity for the Company under the 2016 Equity Plan for the six months ended June 30, 2023.

	2023
		Weighted Average
	Number of	Grant Date
	Shares	Fair Value
Nonvested at beginning of period	36,860	$	20.15
Granted	27,550		17.49
Vested	(30,199)		20.01
Forfeited	(900)		17.49
Nonvested at end of period	33,311	$	17.63

The fair value of restricted stock awards that vested during the first six months of 2023 and 2022 was $523 thousand and $505 thousand, respectively.